Ozanimod Attenuates Human Cerebrovascular Endothelial Derived MMP-9 Activity and Preserves Barrier Properties Following In Vitro Acute Ischemic Injury
Preprint
Abstract
Endothelial integrity is critical in mitigating a vicious cascade of secondary injuries following acute ischemic stroke (AIS). Matrix metalloproteinase-9 (MMP-9), a contributor to endothelial integrity loss, is elevated during stroke and is associated with worsened stroke outcome. We investigated the FDA approved selective sphingosine-1-phosphate receptor 1 (S1PR1) ligand, ozanimod, on the regulation/activity of MMP-9 as well as endothelial barrier components (PECAM-1, claudin-5, and ZO-1) in human brain microvascular endothelial cells (HBMECs) following hypoxia plus glucose deprivation (HGD). We previously reported that S1PR1 activation improves HBMEC integrity; however, specific mechanisms underlying S1PR1 involvement in barrier integrity have not been clearly elucidated. We hypothesized that ozanimod would attenuate an HGD-induced increase in MMP-9 activity which would concomitantly attenuate the loss of integral barrier components. Male HBMECs were treated with ozanimod (0.5nM) or vehicle and exposed to 3h normoxia (21% O 2 ) or HGD (1% O 2 ). Immunoblotting, zymography, qRT-PCR, and immunocytochemical labeling techniques assessed processes related to MMP-9 and barrier markers. We observed that HGD acutely increased MMP-9 activity and reduced claudin-5 and PECAM-1 levels, and ozanimod attenuated these responses. In situ analysis via PROSPER, suggested that attenuation of MMP-9 activity may be a primary factor in maintaining these integral barrier proteins. We also observed that HGD increased intracellular mechanisms associated with augmented MMP-9 activation, however ozanimod had no effect on these targeted factors. Thus, we conclude that ozanimod has the potential to attenuate HGD mediated decreases in HBMEC integrity in part by decreasing MMP-9 activity as well as preserving barrier properties. GraphicalKeywords
This publication has 132 references indexed in Scilit:
- Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD)Journal of Biological Chemistry, 2012
- Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusionNeuroscience, 2012
- Hydrogen peroxide: a Jekyll and Hyde signalling moleculeCell Death & Disease, 2011
- Vascular Cell Adhesion Molecule-1 Expression and Signaling During Disease: Regulation by Reactive Oxygen Species and AntioxidantsAntioxidants & Redox Signaling, 2011
- Extracellular matrix and matrix receptors in blood–brain barrier formation and strokeDevelopmental Neurobiology, 2011
- eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progressionProceedings of the National Academy of Sciences, 2010
- Disruptions of occludin and claudin‐5 in brain endothelial cells in vitro and in brains of mice with acute liver failure†Hepatology, 2009
- Regulation of superoxide dismutase genes: Implications in diseaseFree Radical Biology and Medicine, 2009
- The Kazal motifs of RECK protein inhibit MMP‐9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivoJournal of Cellular and Molecular Medicine, 2008
- Full Pharmacological Efficacy of a Novel S1P1 Agonist That Does Not Require S1P-Like Headgroup InteractionsMolecular Pharmacology, 2008